Oakland, CA, United States of America

Andrea Ambrosi

This inventor holds 2 USPTO granted patents. Top assignee: Gilead Sciences, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrea Ambrosi. Retrieved from https://idiyas.com/inventor/andrea-ambrosi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Andrea Ambrosi: Innovating Immunology in Oakland

Introduction

Andrea Ambrosi, an innovative inventor based in Oakland, California, has made significant contributions to the field of immunology. With one patent to his name, he is dedicated to advancing scientific understanding and medical applications through innovative processes.

Latest Patents

Andrea's patent focuses on "Processes for preparing toll-like receptor modulator compounds." This groundbreaking patent provides methods for synthesizing (R)-2-((2-amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino)-2-methylhexan-1-ol or a salt thereof, along with key intermediates crucial for research and development in immunomodulation.

Career Highlights

Currently, Andrea Ambrosi works at Gilead Sciences, Inc., a biopharmaceutical company renowned for its innovative research and therapeutic products. His role involves working on cutting-edge research that targets significant health challenges, particularly in the realm of immunology.

Collaborations

Throughout his career, Andrea has had the opportunity to collaborate with esteemed colleagues, including Florence J. Bachrach and Pavel Robertovich Badalov. These collaborations have likely fostered a productive research environment, enhancing creativity and scientific progress in their shared projects.

Conclusion

Andrea Ambrosi represents the spirit of innovation in the scientific community. Through his patent and collaborations at Gilead Sciences, Inc., he continues to push the boundaries of immunological research, contributing valuable knowledge and advancements to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…